Oxaliplatin and Liposomal Irinotecan (Plus Trastuzumab for HER2-positive Disease) in Advanced Esophageal and Gastric Adenocarcinoma

Name: Oxaliplatin and Liposomal Irinotecan (Plus Trastuzumab for HER2-positive Disease) in Advanced Esophageal and Gastric Adenocarcinoma
License: Public Domain

University of Wisconsin, Madison

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

esophageal adenocarcinoma, gastric adenocarcinoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 230402
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.